Sigma Healthcare Ltd
ASX:SIG
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.64
3.27
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Net Margin
Sigma Healthcare Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
33.2B AUD |
9%
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
101.2B USD |
1%
|
|
| US |
|
Cencora Inc
NYSE:COR
|
65.1B USD |
0%
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
65.2B USD |
0%
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
47.9B USD |
1%
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
69.5B CNY |
9%
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
66.3B CNY |
2%
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.2B USD |
3%
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
7%
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
64.5B HKD |
1%
|
|
| AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
7.1B USD |
2%
|
Sigma Healthcare Ltd
Glance View
In the competitive landscape of Australia’s healthcare sector, Sigma Healthcare Ltd emerges as a vital cog in the country’s pharmacy and healthcare distribution wheel. Born from a humble beginning, the company has strategically evolved into one of the leading pharmaceutical wholesalers, boasting an extensive distribution network that spans across Australia's vast geography. Sigma supplies both prescription medicines and over-the-counter products to numerous independent and branded pharmacies, including recognizable names such as Amcal and Guardian. This distribution forte encapsulates Sigma’s primary revenue stream, as the company capitalizes on the efficiency of its supply chain operations, ensuring pharmaceuticals are delivered seamlessly from manufacturers directly to the doorsteps of pharmacies and hospitals. Beyond distribution, Sigma has diversified its operations to tap into retail pharmacy franchising, leveraging well-established brands to capture consumer loyalty. Operating under its banner of pharmacy brands, Sigma extends support in the form of marketing, retail advisory, and operational assistance to its franchise network, which in turn, feeds into its profitability margins. The company's strategic foresight into expanding its retail and service offerings further underpins its financial architecture, as it looks to balance its ledger not just through wholesale operations but also via the value-added services offered to its network. By orchestrating a symphony of merchandise management, supply chain prowess, and retail consultancy, Sigma Healthcare Ltd not only sustains its market relevance but also weaves itself deeply into the fabric of Australian healthcare delivery.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Sigma Healthcare Ltd's most recent financial statements, the company has Net Margin of 8.8%.